| Mrs Johannie Margarita Torres, FNP | |
|
7128 Fulton St E, Ada, MI 49301-8413 | |
| (616) 825-3530 | |
| Not Available |
| Full Name | Mrs Johannie Margarita Torres |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 24 Years |
| Location | 7128 Fulton St E, Ada, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467437384 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 4704200103 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Spectrum Health | Grand rapids, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spectrum Health Primary Care Partners | 4587568647 | 1585 |
News Archive
Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. This breakthrough discovery shows that the mutated form of IDH1 produces a metabolite, 2-hydroxyglutarate (2HG), which may contribute to the formation and malignant progression of gliomas, the most common type of brain cancers.
Virtual reality is being used to train and prepare the next generation of paramedics to respond to terrorist attacks and natural disasters.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has entered into a distribution agreement with AngioScore for its AngioSculpt® PTCA Scoring Balloon Catheter for coronary indications in Japan. This is the first of what Volcano believes will be many products distributed by Volcano Japan, which now includes more than 50 direct sales representatives.
With the increasing importance of laboratory tests in diagnosing and treating disease, representatives of the College of American Pathologists (CAP) today presented recommendations to the Food and Drug Administration (FDA) urging increased oversight of laboratory developed tests (LDTs) and "direct-to-consumer" tests. Most genetic tests fall into one or both of these testing categories.
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found. The discovery is a major breakthrough because, until now, genetic aberrations have been seen as the main cause of almost all cancer.
› Verified 8 days ago
| Entity Name | Spectrum Health Primary Care Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235188673 PECOS PAC ID: 4587568647 Enrollment ID: O20031121000091 |
News Archive
Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. This breakthrough discovery shows that the mutated form of IDH1 produces a metabolite, 2-hydroxyglutarate (2HG), which may contribute to the formation and malignant progression of gliomas, the most common type of brain cancers.
Virtual reality is being used to train and prepare the next generation of paramedics to respond to terrorist attacks and natural disasters.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has entered into a distribution agreement with AngioScore for its AngioSculpt® PTCA Scoring Balloon Catheter for coronary indications in Japan. This is the first of what Volcano believes will be many products distributed by Volcano Japan, which now includes more than 50 direct sales representatives.
With the increasing importance of laboratory tests in diagnosing and treating disease, representatives of the College of American Pathologists (CAP) today presented recommendations to the Food and Drug Administration (FDA) urging increased oversight of laboratory developed tests (LDTs) and "direct-to-consumer" tests. Most genetic tests fall into one or both of these testing categories.
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found. The discovery is a major breakthrough because, until now, genetic aberrations have been seen as the main cause of almost all cancer.
› Verified 8 days ago
| Entity Name | Pennock Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518186295 PECOS PAC ID: 4587551015 Enrollment ID: O20040301000595 |
News Archive
Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. This breakthrough discovery shows that the mutated form of IDH1 produces a metabolite, 2-hydroxyglutarate (2HG), which may contribute to the formation and malignant progression of gliomas, the most common type of brain cancers.
Virtual reality is being used to train and prepare the next generation of paramedics to respond to terrorist attacks and natural disasters.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has entered into a distribution agreement with AngioScore for its AngioSculpt® PTCA Scoring Balloon Catheter for coronary indications in Japan. This is the first of what Volcano believes will be many products distributed by Volcano Japan, which now includes more than 50 direct sales representatives.
With the increasing importance of laboratory tests in diagnosing and treating disease, representatives of the College of American Pathologists (CAP) today presented recommendations to the Food and Drug Administration (FDA) urging increased oversight of laboratory developed tests (LDTs) and "direct-to-consumer" tests. Most genetic tests fall into one or both of these testing categories.
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found. The discovery is a major breakthrough because, until now, genetic aberrations have been seen as the main cause of almost all cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Johannie Margarita Torres, FNP 100 Michigan St Ne # Mc845, Grand Rapids, MI 49503-2560 Ph: () - | Mrs Johannie Margarita Torres, FNP 7128 Fulton St E, Ada, MI 49301-8413 Ph: (616) 825-3530 |
News Archive
Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. This breakthrough discovery shows that the mutated form of IDH1 produces a metabolite, 2-hydroxyglutarate (2HG), which may contribute to the formation and malignant progression of gliomas, the most common type of brain cancers.
Virtual reality is being used to train and prepare the next generation of paramedics to respond to terrorist attacks and natural disasters.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has entered into a distribution agreement with AngioScore for its AngioSculpt® PTCA Scoring Balloon Catheter for coronary indications in Japan. This is the first of what Volcano believes will be many products distributed by Volcano Japan, which now includes more than 50 direct sales representatives.
With the increasing importance of laboratory tests in diagnosing and treating disease, representatives of the College of American Pathologists (CAP) today presented recommendations to the Food and Drug Administration (FDA) urging increased oversight of laboratory developed tests (LDTs) and "direct-to-consumer" tests. Most genetic tests fall into one or both of these testing categories.
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found. The discovery is a major breakthrough because, until now, genetic aberrations have been seen as the main cause of almost all cancer.
› Verified 8 days ago
Amy Renae Bell, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7128 Fulton St E, Ada, MI 49301 Phone: 616-825-3530 Fax: 616-825-3535 | |
Mrs. Michelle Lynn Degraaf, MSN, ANP, BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 989 Spaulding Ave Se, Ada, MI 49301 Phone: 616-481-6877 | |
Jennifer Lynne Dykstra, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7128 Fulton St E, Ada, MI 49301 Phone: 616-825-3530 | |
Rachel Kloosterman, MSN RN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6741 Fulton St E, Ada, MI 49301 Phone: 616-320-5330 Fax: 616-320-5331 | |
Colleen Elizabeth Tillema, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7128 Fulton St E, Ada, MI 49301 Phone: 616-825-3530 | |
Rachel Anne Giwa, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 510 Spaulding Hills Cir Se Apt 202, Ada, MI 49301 Phone: 248-563-7875 |